Results 1 to 10 of about 14,850 (297)

Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database [PDF]

open access: goldBMC Anesthesiology, 2022
Background Intravenous dantrolene is often prescribed for hypermetabolic syndromes other than the approved indication of malignant hyperthermia (MH). To clarify the extent of and indications for dantrolene use in conditions other than MH, we sought to ...
Stanley N. Caroff   +7 more
doaj   +3 more sources

Dantrolene Prevents the Lymphostasis Caused by Doxorubicin in the Rat Mesenteric Circulation [PDF]

open access: goldFrontiers in Pharmacology, 2021
Background and Purpose: Doxorubicin (DOX) is a risk factor for arm lymphedema in breast cancer patients. We reported that DOX opens ryanodine receptors (RYRs) to enact “calcium leak,” which disrupts the rhythmic contractions of lymph vessels (LVs) to ...
Serena Van   +8 more
doaj   +3 more sources

Intranasal administration of dantrolene increased brain concentration and duration.

open access: yesPLoS ONE, 2020
Dantrolene has been demonstrated to be neuroprotective for multiple neurodegenerative diseases. However, dantrolene's limited penetration into the CNS hampers its effectiveness as a neuroprotective agent.
Jintao Wang   +7 more
doaj   +2 more sources

The effect of long-term oral dantrolene on the neuromuscular action of rocuronium: a case report [PDF]

open access: goldKorean Journal of Anesthesiology, 2014
Oral dantrolene causes a dose-dependent depression of skeletal muscle contractility. A 52-year-old man treated with oral dantrolene for spasticity after spinal cord injury was scheduled to undergo irrigation and drainage of a thigh abscess under general ...
Jinwoo Jeon   +4 more
doaj   +3 more sources

A phase Ib/IIa clinical trial of dantrolene sodium in patients with Wolfram syndrome

open access: yesJCI Insight, 2021
BACKGROUND Wolfram syndrome is a rare ER disorder characterized by insulin-dependent diabetes mellitus, optic nerve atrophy, and progressive neurodegeneration.
Damien Abreu   +16 more
doaj   +2 more sources

The combination of dantrolene and nimodipine effectively reduces 5-HT-induced vasospasms in diabetic rats

open access: yesScientific Reports, 2021
Diabetics have a higher risk of developing cerebral vasospasms (CVSP) after subarachnoid hemorrhagic stroke than non-diabetics. Serotonin (5-HT) is one of the key vasoconstrictors released in the hemorrhagic blood and an important contributor to the ...
Marie Román   +3 more
doaj   +2 more sources

Targeting RyR Activity Boosts Antisense Exon 44 and 45 Skipping in Human DMD Skeletal or Cardiac Muscle Culture Models [PDF]

open access: yesMolecular Therapy: Nucleic Acids, 2019
Systemic delivery of antisense oligonucleotides (AO) for DMD exon skipping has proven effective for reframing DMD mRNA, rescuing dystrophin expression, and slowing disease progression in animal models.
Florian Barthélémy   +6 more
doaj   +3 more sources

The effects of dantrolene in the presence or absence of ryanodine receptor type 1 variants in individuals predisposed to malignant hyperthermia [PDF]

open access: bronzeAnaesthesia and Intensive Care, 2022
Dantrolene is currently the only drug known to specifically treat malignant hyperthermia (MH) crises. Although dantrolene attenuates Ca2+ disorders by acting mainly on the ryanodine receptor type 1 (RYR1), some patients who manifest MH without RYR1 ...
Yuko Noda   +7 more
openalex   +2 more sources

Repurposing Dantrolene for Long-Term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx Mouse [PDF]

open access: goldMolecular Therapy: Nucleic Acids, 2018
Duchenne muscular dystrophy (DMD) is caused by mutations in DMD, resulting in loss of dystrophin, which is essential to muscle health. DMD “exon skipping” uses anti-sense oligo-nucleotides (AONs) to force specific exon exclusion during mRNA processing to
Derek W. Wang   +8 more
doaj   +2 more sources

Rapid Dantrolene Administration with Body Temperature Monitoring Is Associated with Decreased Mortality in Japanese Malignant Hyperthermia Events [PDF]

open access: hybridBioMed Research International, 2023
Purpose Malignant hyperthermia (MH) is a rare genetic disorder but one of the most severe complications of general anesthesia. The mortality rate of MH has dropped from 70% in the 1960s to 15% because of dantrolene, the only currently accepted specific ...
Yukari Toyota   +12 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy